Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Abbvie Inc | 210.1B | 28.3x | -2.82% |
Amgen Inc | 114.0B | 20.9x | +6.33% |
AstraZeneca PLC | 168.8B | 85.6x | +1.74% |
Bayer AG | 49.1B | 193.1x | --- |
Catalent Inc | 21.0B | 38.5x | +28.57% |
Eisai Co Ltd | 18.2B | 31.1x | -5.19% |
GlaxoSmithKline PLC | 102.2B | 18.3x | -7.91% |
Horizon Therapeutics PLC | 22.6B | 43.1x | +48.17% |
I-Mab | 4.1B | -161.3x | --- |
Johnson & Johnson | 419.6B | 23.8x | -0.30% |
Merck & Co Inc | 185.3B | 29.0x | +12.21% |
Novartis AG | 194.6B | 18.4x | +4.08% |
Novo Nordisk A/S | 189.9B | 35.2x | +5.89% |
Organogenesis Holdings Inc | 1.2B | 20.6x | --- |
Royalty Pharma PLC | 22.9B | 26.2x | --- |
Teva Pharmaceutical Industries Ltd | 9.2B | 12.3x | --- |
Amneal Pharmaceuticals Inc | 1.2B | 45.4x | --- |
Amphastar Pharmaceuticals Inc | 976.6M | 28.2x | --- |
avVaa World Health Care Products Inc | 40.9M | 900.0x | --- |
BioDelivery Sciences International Inc | 254.9M | 8.6x | --- |
Collegium Pharmaceutical Inc | 608.8M | 6.6x | --- |
Corcept Therapeutics Inc | 2.4B | 24.9x | --- |
Cyanotech Corp | 21.5M | 10.3x | --- |
Dr Reddy's Laboratories Ltd | 10.1B | 44.1x | -2.39% |
Earth Science Tech Inc | 1.1M | 0.4x | --- |
Eli Lilly and Co | 234.9B | 37.5x | +24.60% |
Emergent BioSolutions Inc | 2.3B | 10.1x | +24.00% |
Harmony Biosciences Holdings Inc | 2.1B | 181.3x | --- |
Innoviva Inc | 1.1B | 5.2x | --- |
Integrated Biopharma Inc | 29.4M | 4.2x | +40.73% |
LifeVantage Corp | 81.4M | 6.2x | +16.55% |
Natural Alternatives International Inc | 82.2M | 7.0x | +3.26% |
OPKO Health Inc | 2.6B | 32.7x | --- |
Pfizer Inc | 304.6B | 16.4x | +2.24% |
Prestige Consumer Healthcare Inc | 2.9B | 16.3x | +11.60% |
Procyon Corp | 2.8M | 5.7x | +50.31% |
Sanofi SA | 119.6B | 16.9x | +24.05% |
SIGA Technologies Inc | 567.0M | 36.4x | --- |
Takeda Pharmaceutical Co Ltd | 43.1B | 10.1x | --- |
Taro Pharmaceutical Industries Ltd | 2.0B | 267.1x | --- |
Titan Pharmaceuticals Inc | 12.7M | 2.5x | --- |
United-Guardian Inc | 69.8M | 16.8x | -6.43% |
Unrivaled Brands Inc | 124.9M | 14.9x | --- |
Adamis Pharmaceuticals Corp | 101.5M | -1.7x | --- |
Aerie Pharmaceuticals Inc | 484.0M | -2.8x | --- |
ANI Pharmaceuticals Inc | 504.3M | -21.6x | --- |
Aptorum Group Ltd | 59.1M | -18.2x | --- |
Aquestive Therapeutics Inc | 194.4M | -2.8x | --- |
Assertio Holdings Inc | 60.3M | -1.5x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
| Company | Dividend Yield |
|---|---|
United-Guardian, Inc. | 9.81% |
Takeda Pharmaceutical Co Ltd (ADR) | 5.96% |
GlaxoSmithKline plc (ADR) | 5.34% |
AbbVie Inc | 4.75% |
Sanofi SA (ADR) | 4.10% |